Didier Scherrer
Director Técnico/Científico/I+D en ABIVAX .
Fortuna: 564 574 $ al 30/04/2024
Perfil
Didier Scherrer is currently the Chief Scientific Officer at Abivax SA. Previously, he held positions as the Chief Executive Officer & Scientific Director at Splicos SAS, Research Director at Entelos, Inc. from 2000 to 2005, Associate Director-Research Department at AstraZeneca SAS from 2005 to 2008, and Head-Research at LFB Biotechnologies SASU in 2008-2009.
Dr. Scherrer obtained his doctorate degree from Harvard Medical School and Stanford University School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ABIVAX SA
0.06% | 29/02/2024 | 35 773 ( 0.06% ) | 564 574 $ | 30/04/2024 |
Cargos activos de Didier Scherrer
| Empresas | Cargo | Inicio |
|---|---|---|
| ABIVAX | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Didier Scherrer.
| Empresas | Cargo | Fin |
|---|---|---|
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Director Técnico/Científico/I+D | 01/09/2009 |
AstraZeneca SAS
 AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Corporate Officer/Principal | 01/06/2008 |
Entelos, Inc.
 Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Director Técnico/Científico/I+D | 01/09/2005 |
Splicos SAS
 Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Director Ejecutivo | - |
Formación de Didier Scherrer.
| Harvard Medical School | Doctorate Degree |
| Stanford University School of Medicine | Doctorate Degree |
| Louis Pasteur University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABIVAX | Health Technology |
| Empresas privadas | 4 |
|---|---|
Splicos SAS
Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Commercial Services |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Technology Services |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
- Bolsa de valores
- Insiders
- Didier Scherrer